Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05057377 · ClinicalTrials.gov registry record
Estimating Highest Capacity Performance During Evaluation of Walking for Individuals With Traumatic Brain Injury
A clinical trial, sponsored by The University of Texas Medical Branch, Galveston.
- Completed
- Registry status
- 16
- Enrollment target
NCT05057377: Completed study, sponsored by The University of Texas Medical Branch, Galveston.
NCT05057377 is a clinical trial that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05057377 has completed, sponsored by The University of Texas Medical Branch, Galveston.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
Traumatic brain injury (TBI) due to trauma and/or neurologic disease is a leading cause of long-term disability in the United States. The loss of balance for people with a traumatic brain injury can have a large effect on their walking abilities and this can come with a number of challenges. There is a greater risk of falling after being discharged from the hospital. In addition, people are more likely to become sedentary after TBI, which leads to the loss of muscle strength. To help provide the best care, clinicians need accurate measurements when people begin their therapy, as well as throughout to ensure they are making appropriate progress. The tests currently used by clinicians may not provide the most accurate measurements that show what a person is capable of physically doing. The study you are being asked to participate in aims to provide more accurate measurements by using a robotic treadmill device and by assessing motivating factors that are important to you. The treadmill device will allow us to more accurately test your walking ability in a safe, fall-free environment.
Primary Outcome
The 10-meter walk test assess walking speed in meters per second over a short duration.
Interventions
- DIAGNOSTIC_TEST Standard Overground Assessment
- DIAGNOSTIC_TEST Robotic Safety-Environment Assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2021-09-22 |
| Est. Completion | 2022-08-31 |
What the finished NCT05057377 record still lists
NCT05057377 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Standard Overground Assessment is the first listed.
NCT05057377 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05057377 about?
NCT05057377 is a clinical study titled "Estimating Highest Capacity Performance During Evaluation of Walking for Individuals With Traumatic Brain Injury". Traumatic brain injury (TBI) due to trauma and/or neurologic disease is a leading cause of long-term disability in the United States. The loss of balance for people with a traumatic brain injury can have a large effect on their walking abilities and this can come with a number of challenges. There i...
What is the current status of trial NCT05057377?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2021-09-22. Estimated completion is 2022-08-31.
What interventions are being tested in trial NCT05057377?
The interventions under investigation include: Standard Overground Assessment (DIAGNOSTIC_TEST), Robotic Safety-Environment Assessment (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05057377?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI